Dan Groman - 17 Apr 2023 Form 4 Insider Report for Enfusion, Inc.

Role
Chief Technology Officer
Signature
/s/ Matthew Campobasso, as Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
17 Apr 2023
Net transactions value
-$37,452
Form type
4
Filing time
19 Apr 2023, 16:15:31 UTC
Previous filing
21 Mar 2023
Next filing
27 Apr 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ENFN Class A Common Stock Sale $37,452 -3,877 -4.5% $9.66 82,102 17 Apr 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on December 14, 2022.